Cost Considerations in the Drug Treatment of Hypertension Norman M. Kaplan Current Opinion 17 November 2012 Pages: 283 - 285
Drug Utilisation Patterns in the Third World Jawahar S. BapnaChakra D. TripathiUma Tekur Leading Article 17 November 2012 Pages: 286 - 294
Treatment of Urinary Tract Infection Richard J. PlumridgeClayton L. Golledge Review Article 17 November 2012 Pages: 295 - 306
Clinical and Economic Factors in the Treatment of Onychomycosis Thomas R. EinarsonAditya K. GuptaSteve Arikian Review Article 17 November 2012 Pages: 307 - 320
Do Physicians’ Perceptions of Drug Costs Influence Their Prescribing? Mandy RyanBrian YuleRoss J. Taylor Original Research Article 17 November 2012 Pages: 321 - 331
The Economic Costs of Caring for People with HIV Infection and AIDS in England and Wales Stavros PetrouMary DooleyAdrian Renton Original Research Article 17 November 2012 Pages: 332 - 340
The November 1995 Revised Australian Guidelines for the Economic Evaluation of Pharmaceuticals Paul C. Langley Special Article 17 November 2012 Pages: 341 - 352
Industry Comment on the 1995 Revised Australian Pharmacoeconomic Guidelines Mendel P. GroblerKelly Macarounas-KirchmannMichael Stafford Special Article 17 November 2012 Pages: 353 - 356
Granisetron Greg L. PloskerPaul Benfield Pharmacoeconomic Drug Evaluation 17 November 2012 Pages: 357 - 374